跳至主要内容
临床试验/NCT03457506
NCT03457506已完成不适用

Intra-individual Patient-based Comparison of Conventional and Digital PET/CT Scanners

Isala1 个研究点 分布在 1 个国家目标入组 225 人开始时间: 2018年1月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Isala
入组人数
225
试验地点
1
主要终点
Diagnostic outcome of the PET/CT study

研究概览

简要总结

In this study, the investigators will analyze the impact of digital PET/CT on the final diagnostic conclusion of the scan in patients with lung cancer, breast cancer, esophageal cancer and a group of mescellaneous cancers.

详细描述

There will be a single injection of the PET radiopharmaceutical FDG, followed by a conventional PET/CT scan and a digital PET scan, in this order or vice versa.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • •referred to Isala for a clinically indicated FDG-PET/CT scan
  • •suspected or proven lung cancer, esophageal cancer, breast cancer or miscellaneous cancer, either as a primary diagnosis or follow-up study
  • •signed informed consent

排除标准

  • •A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • •age < 18 years
  • •incapacitated adults
  • •prisoners
  • •pregnant patients
  • •unable to undergo two consecutive PET/CT scans

研究组 & 干预措施

Patients undergo a digital PET/CT

Other

Single arm prospective study of paired PET scans. Patients who are referred to the nuclear medicine department to undergo a PET scan, will undergo a PET/CT scan on the conventional scanner as well as the digital PET/CT scanner.

干预措施: Digital PET/CT scan (Diagnostic Test)

结局指标

主要结局

Diagnostic outcome of the PET/CT study

时间窗: approximately 2 hours

次要结局

  • PET image quality(approximately 2 hours)

研究者

发起方
Isala
申办方类型
Other
责任方
Principal Investigator
主要研究者

Piet Jager

Principal Investigator

Isala

研究点 (1)

Loading locations...

相似试验